Annual Report 2021

NOTESTOTHE CONSOLIDATED FINANCIAL STATEMENTS For the year ended 31 December 2021 155 The United Laboratories International Holdings Limited Annual Report 2021 45. INFORMATION ABOUT THE STATEMENT OF FINANCIAL POSITION OF THE COMPANY (Continued) (b) Reserves Share premium Treasury stock Retained profits Total RMB’000 RMB’000 RMB’000 RMB’000 At 1 January 2020 2,446,154 – 1,292,950 3,739,104 Loss and total comprehensive expense for the year – – (319,584) (319,584) Dividends recognised as distribution (Note 15) – – (128,140) (128,140) Issue of shares upon conversion of convertible bonds (Note 29) 1,359,541 – – 1,359,541 At 31 December 2020 3,805,695 – 845,226 4,650,921 Loss and total comprehensive expense for the year – – (308,830) (308,830) Dividends recognised as distribution (Note 15) – – (220,847) (220,847) Repurchase and cancellation of shares (23,267) (17,653) – (40,920) Transaction costs attributable to repurchase and cancellation of shares – (162) – (162) At 31 December 2021 3,782,428 (17,815) 315,549 4,080,162